Epigenetic Reader Domain Inhibitors

Catalog No.	Product Name	Information
F2193	PABPN1 Rabbit mAb	PABP2,PABPN1
F2939	SF2 Rabbit mAb	SF2,SF2/ASF,SRSF1
E1926	IBG1	IBG1 (PROTAC BRD4 Degrader-19) is a PROTAC-like degrader specifically targeting BET bromodomains with a DC50 of 0.15 nM for BRD4. It consists of the BET inhibitor JQ1 linked to E7820 and functions through CRL4-DCAF16.
E1994	DBr-1	DBr-1 is a DCAF1-BRD9 PROTAC, created by linking the BRD9 binder BI-956448 to the DCAF1 scaffold via a piperidine-aliphatic carbon linker. It is a potent and selective degrader of BRD9 with a DC50 of 90 nM. It overcomes intrinsic resistance to VHL-degraders, positioning DCAF1-PROTACs as a promising strategy to counter ligase-mediated resistance.
E4713	BBC0403	BBC0403 is a small-molecule selective inhibitor of Bromodomain-containing protein 2(BRD2) with Kds of 7.64 μM and 41.37 μM for BRD2 (BD2) and BRD2 (BD1), respectively. It is a potential intra-articular injectable therapeutic agent for treating osteoarthritis (OA).
≡ All Epigenetic Reader Domain Inhibitors

New Epigenetic Reader Domain Inhibitors